| CAS: | 10563-70-9 | |||||||||
| 分子式: | C21H25N·HCl | |||||||||
| 分子量: | 327.89 | |||||||||
| 中文名称: |
| |||||||||
| 英文名称: |
| |||||||||
| 用途: | Melitracen hydrochloride是一种潜在的dopamine D1/2 receptor拮抗剂,具有抗抑郁作用。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||
| T873670 | MACKLIN | Melitracen hydrochloride | 99% | 243元/5mg; 614元/25mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||
储存:-20℃ 状态:粉末 | |||||||||||||||||||||||||||||||||||||||||||||||
| M795560 | MACKLIN | Melitracen hydrochloride | 10mM in DMSO | 648元/1ml; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||
| SML2600 | Sigma-Aldrich | Melitracen hydrochloride | ≥98% (HPLC) | 1161.11元/10 MG; 3747.22元/50 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||
产品说明 生化/生理作用 Melitracen is a tricyclic antidepressant (TCA) that likely exerts its in vivo efficacy similarly as imipramine and amitriptyline by inhibiting serotonin-norepinephrine reuptake. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||
| BP1151 | Melitracen hydrochloride | British Pharmacopoeia (BP) Reference Standard | 2978.17元/25 MG; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||
| 516505 | Fluorochem | Melitracen hydrochloride | 0.97 | 660元/250mg; 1298元/1g; 3784元/5g; 6380元/10g; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||
基本信息
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||